Tag Archives: biotech industry

The Burrill Report: Pushing Policies in a Changed Washington

The Burrill Report’s Daniel Levine talks to BIO’s Alan Eisenberg regarding recent fluctuations in the financial markets and the impact on public policy. Eisenberg discusses implementation of BIO’s legislative proposals and the outlook for the industry. BIO will be hosting the BIO Investor Forum to bring together industry leaders to discuss these recent developments that could have a major influence in helping to shape the future of biotechnology.

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , ,

State Deficits to Shrink & Taxes Drop – Good News for Biotech

Michigan State Capitol dome interior, Lansing, MI

Forecasters at the National Conference of State Legislatures’ 2011 Legislative Summit expect a dramatic reduction of state deficits in the coming years, along with business-friendly tax-cuts. The projections are based on a survey of budget officials in all 50 states last month, said Corina Eckl, director of state services for NCSL. Eckl also noted an emerging trend in which state governors and legislatures are allowing for the expiration of temporary business taxes. Notably, the Michigan Business Read More >

Business of Biotech  |  1 Comment  |  Email This Post
Tags: , , , , , ,

Fall Preview: Business Development Events

Banner

Now that the Business Forum and International Convention are behind us, our Business Development department has been gearing up for a very busy Fall schedule.   The Line-Up For our first Fall event, BIO returns to India for its 2nd annual BIO India International Partnering Conference September 21st and 22nd.  Last year’s conference attracted more than 400 attendees representing 220 companies, from 17 countries around the world, – who scheduled over 750 meetings.  We’ve had Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Raising the Stakes in Biotech

JimGreenwood

Small biotech companies continue to struggle to obtain funding as capital markets remain tight. The S&P downgrade may create even tighter credit markets and raise the cost of available credit, for small and large companies. To the extent that the downgrade leads capital flows out of the U.S., that hurts biotech. Biotech’s contributions to the world are critically needed. Our industry holds great promise for curing and treating many prevalent diseases, such as Alzheimer’s, cancer, Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Public Opinion: What do voters think about biotechnology?

Graph

The majority of voters recognize the important work being conducted at biotech companies and place a high value on the industry’s contributions. After only a brief neutral description of the biotechnology industry, 87% of those polled have a favorable image of the biotech industry. More than three-quarters of Americans surveyed are convinced that biotech is working every day on curing diseases such as Alzheimer’s, cancer, diabetes and Parinson’s. Furthermore, they believe that these cures will Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,